TY - JOUR T1 - Research progress on microRNA in gout. AU - Xie,Jing, AU - He,Cuixia, AU - Su,Yue, AU - Ding,Yuzhou, AU - Zhu,Xingyu, AU - Xu,Yuanyuan, AU - Ding,Jiaxiang, AU - Zhou,Huan, AU - Wang,Hongju, Y1 - 2022/10/20/ PY - 2022/06/29/received PY - 2022/09/26/accepted PY - 2022/11/7/entrez PY - 2022/11/8/pubmed PY - 2022/11/8/medline KW - biomarker KW - cellular signaling pathway KW - gout KW - microRNA KW - treatment SP - 981799 EP - 981799 JF - Frontiers in pharmacology JO - Front Pharmacol VL - 13 N2 - Gout is a common form of arthritis caused by the deposition of sodium urate crystals in the joints and tissues around them. MicroRNAs (miRNAs) are noncoding RNAs that have been shown to be involved in regulating the pathogenesis of gout through multiple cellular signaling pathways, which may be potential targets for the treatment of gout. In this review, we systematically discuss the regulatory roles of related miRNAs in gout, which will provide help for the treatment of gout and miRNAs is expected to become a potential biomarker for gout diagnosis. SN - 1663-9812 UR - https://www.unboundmedicine.com/medline/citation/36339582/Research_progress_on_microRNA_in_gout_ DB - PRIME DP - Unbound Medicine ER -